Ipamorelin
Ipamorelin is a selective pentapeptide GH secretagogue and ghrelin receptor agonist (CAS 170851-70-4) at 99.4% HPLC-verified purity. Minimal cortisol/prolactin effects, studied for GH axis research.
Ipamorelin — Research Summary
Ipamorelin is a selective pentapeptide growth hormone secretagogue and ghrelin receptor agonist. It stimulates pituitary GH release with high selectivity — minimal effects on cortisol, prolactin, ACTH, or aldosterone have been observed in preclinical studies, distinguishing it from earlier GH secretagogues. Research applications include GH axis studies, pulse amplitude analysis, and metabolic regulation research. Ipamorelin is commonly studied alongside CJC-1295 for synergistic GH release profiling. For research use only.
Researchers Also Study
For research use only. Not for human or animal consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used solely for lawful laboratory research.